CLYM
Climb Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.52
+6.37%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.18x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 0.72x
Liquidity & coverage
- Current ratio
- 31.45x
- Quick ratio
- 31.45x
- Cash ratio
- 30.86x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $180.7M
Cash & dividend
- FCF / debt
- -40.39x
- Cash flow / debt
- -40.11x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026